Pregnancy Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian
PUQE-N
Case-cohort Validation Study of Pregnancy Unique Questionnaire of Emesis (PUQE) in Norwegian
1 other identifier
observational
69
1 country
2
Brief Summary
Nausea in early pregnancy (emesis gravidarum) is very common but most often self-limiting. Hyperemesis gravidarum; where nausea and vomiting is severe and protracted is potentially dangerous for the woman and her foetus and necessitates hospital treatment. An English questionnaire (PUQE; Pregnancy Unique Questionnaire of Emesis) exists that can differentiate between uncomplicated emesis and the severe hyperemesis condition. This questionnaire has been translated to Norwegian. The investigators want to test the ability of this questionnaire to differentiate the grade of nausea/vomiting between a group of presumed normal pregnant woman and patients treated for hyperemesis gravidarum in a Norwegian population. The investigators also want to relate the PUQE questionnaire scoring to the women/patients' self-reported nutritional intake during 24 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2013
CompletedFirst Posted
Study publicly available on registry
April 22, 2013
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedMarch 30, 2015
March 1, 2015
11 months
April 8, 2013
March 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy Unique Questionnaire of Emesis (PUQE) score reported by hyperemesis patients versus normal pregnant women
Pregnancy Unique Questionnaire of Emesis (PUQE) score range from 3 to 15. Scores reported for the first 24 hours after inclusion will be compared between hyperemesis patients and healthy pregnant control women
24 hours after inclusion
Secondary Outcomes (1)
Pregnancy Unique Questionnaire of Emesis (PUQE) score in relation to self reported 24 hours nutritional intake registration (estimated caloric intake)in hyperemesis patients versus normal pregnant women
24 hours after inclusion
Other Outcomes (4)
Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score from hospital admittance to discharge
From hospital admission to discharge, mean 7 days
Pregnancy Unique Questionnaire of Emesis (PUQE) score at inclusion related to change in patient weight (kg)from start of pregnancy to inclusion for hyperemesis patients versus normal pregnant women
From pre-pregnancy to inclusion (mean 9 weeks pregnancy length)
Change of Pregnancy Unique Questionnaire of Emesis (PUQE) score and patient weight (kg)
From inclusion to delivery (mean 7 months)
- +1 more other outcomes
Study Arms (2)
Hyperemesis gravidarum
Women diagnosed with hyperemesis gravidarum admitted to hospital Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered
Healthy pregnant women
Women with presumed normal pregnancy Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered
Interventions
For hyperemesis gravidarum patients the Pregnancy Unique Questionnaire of Emesis (PUQE) (3 questions regarding the amount of nausea and vomiting during 24 hours) will be answered both at hospital admittance and discharge. For control patients the questionnaire will be answered at inclusion.
A nutritional intake form where relevant food and liquid items can be checked prospectively after consummation during 24 hours. This form will be filled in starting the morning following inclusion.
Eligibility Criteria
Hyperemesis patients; recruited from university hospital clinic (normally 60 patients admitted during 12 months) Control paitients recruited from primary care/private practice out-patient gynaecologists
You may qualify if:
- Pregnant healthy women (controls)
- Patients admitted to hospital for hyperemesis gravidarum
You may not qualify if:
- Unable to understand and read/write Norwegian
- Conditions other than hyperemesis leading to nausea/vomiting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
Dpt Obstetrics Gynaecology, Stavanger University Hospital
Stavanger, Rogaland, 4000, Norway
Related Publications (3)
Lacasse A, Rey E, Ferreira E, Morin C, Berard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008 Jan;198(1):71.e1-7. doi: 10.1016/j.ajog.2007.05.051.
PMID: 18166311BACKGROUNDKoren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, Navioz Y, Ungar WJ. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol. 2005 Apr;25(3):241-4. doi: 10.1080/01443610500060651.
PMID: 16147725BACKGROUNDvan Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol. 1995 May;172(5):1585-91. doi: 10.1016/0002-9378(95)90501-4.
PMID: 7755076BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jone Trovik, MD, PhD
Haukeland University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 9 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2013
First Posted
April 22, 2013
Study Start
May 1, 2013
Primary Completion
April 1, 2014
Study Completion
January 1, 2015
Last Updated
March 30, 2015
Record last verified: 2015-03